<DOC>
	<DOCNO>NCT02330458</DOCNO>
	<brief_summary>Goal prospectively determine stool calprotectin change bowel wall thickness hyperemia , see small bowel ultrasound , week 0 , 14 , 54 use predict response week 54 infliximab pediatric patient small bowel Crohn 's Disease .</brief_summary>
	<brief_title>The Role Small Bowel Ultrasound Initiation Infliximab Crohn 's Disease Patients</brief_title>
	<detailed_description>We examine whether non-invasive disease monitoring tool bowel wall thickness measure small bowel ultrasound ( SBUS ) mucosal inflammation measure fecal calprotectin , independently associate infliximab durability .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Age 623 year Initiating Infliximab therapy Crohns disease involve distal small bowel +/ proximal colon Willingness undergo SBUS fecal calprotectin collection prior start infliximab week 14 week 54 Able give consent patient and/or legal guardian Ulcerative colitis nonCrohn 's Disease patient Lack small bowel disease Patients start alternative therapy Unable unwilling provide consent</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>23 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Crohn 's disease</keyword>
	<keyword>Pediatric IBD</keyword>
	<keyword>small bowel ultrasound</keyword>
	<keyword>infliximab</keyword>
</DOC>